SCHEMBL13042989

SCHEMBL13042989

Cc1cc(-c2ccc3c(-c4ccccc4)c4cc(-c5cc(C)c6c(c5)nc(-c5ccccc5)n6-c5ccccc5)ccc4c(-c4ccccc4)c3c2)cc2nc(-c3ccccc3)n(-c3ccccc3)c12

nearest known ligand 0.39

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.39
KMT2A Q03164 3/20 0.39
HSP90AA1 P07900 1/20 0.39
MAPT P10636 1/20 0.39
ALDH1A1 P00352 7/20 0.38
GAA P10253 2/20 0.38
LMNA P02545 1/20 0.37
HCAR1 Q9BXC0 1/20 0.37
AVPR1A P37288 1/20 0.37
HTT P42858 1/20 0.36
ESR1 P03372 2/20 0.36
ESR2 Q92731 1/20 0.36
RAB9A P51151 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
MDM2 Q00987 1/20 0.35
POLB P06746 1/20 0.34
SIRT2 Q8IXJ6 1/20 0.34
SIRT1 Q96EB6 1/20 0.34
PTGER4 P35408 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13042839 0.99 MEN1 (0.41) MEN1KMT2AHSP90AA1MAPTALDH1A1
SCHEMBL13042933 0.99 MEN1 (0.41) MEN1KMT2AHSP90AA1MAPTALDH1A1
SCHEMBL13042796 0.98 MEN1 (0.43) MEN1KMT2AHSP90AA1MAPTALDH1A1
SCHEMBL13043055 0.90 ALDH1A1 (0.43) MEN1KMT2AHSP90AA1MAPTALDH1A1
SCHEMBL13042845 0.84 MEN1 (0.43) MEN1KMT2AHSP90AA1MAPTALDH1A1
SCHEMBL14440655 0.84 MAPT (0.39) MEN1KMT2AHSP90AA1MAPTALDH1A1
SCHEMBL13042803 0.83 MEN1 (0.45) MEN1KMT2AHSP90AA1MAPTALDH1A1
SCHEMBL13043059 0.82 MEN1 (0.42) MEN1KMT2AHSP90AA1MAPTALDH1A1
SCHEMBL13042949 0.82 ESR1 (0.48) MEN1KMT2AHSP90AA1MAPTALDH1A1
SCHEMBL13042864 0.81 ESR1 (0.45) MEN1KMT2AHSP90AA1MAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7833632-B2 Nitrogenous heterocycle derivative, and organic electroluminescent element employing the same IDEMITSU KOSAN CO., LTD. (JP) 2010-11-16 US disclosed
US-7833632-B2 Nitrogenous heterocycle derivative, and organic electroluminescent element employing the same IDEMITSU KOSAN CO., LTD. (JP) 2010-11-16 US disclosed
US-20070200490-A1 Nitrogenous Heterocycle Derivative, And Organic Electroluminescent Element Employing The Same IDEMITSU KASON CO.LTD (JP) 2007-08-30 US disclosed
US-20070200490-A1 Nitrogenous Heterocycle Derivative, And Organic Electroluminescent Element Employing The Same IDEMITSU KASON CO.LTD (JP) 2007-08-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070200490-A1 Nitrogenous Heterocycle Derivative, And Organic Electroluminescent Element Employing The Same RPS3A, NCOA3, HNRNPA0 MEN1 2041/4885KMT2A 529/4885HSP90AA1 1931/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.